Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Cash from Financing Activities (2016 - 2026)

Gyre Therapeutics has reported Cash from Financing Activities over the past 16 years, most recently at $318000.0 for Q4 2025.

  • Quarterly Cash from Financing Activities fell 67.01% to $318000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.4 million through Dec 2025, up 1059.75% year-over-year, with the annual reading at $24.4 million for FY2025, 1059.75% up from the prior year.
  • Cash from Financing Activities was $318000.0 for Q4 2025 at Gyre Therapeutics, down from $365000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $49.5 million in Q1 2021 and troughed at -$45.0 million in Q3 2022.
  • The 5-year median for Cash from Financing Activities is $318000.0 (2025), against an average of $2.0 million.
  • Year-over-year, Cash from Financing Activities crashed 48612.5% in 2023 and then skyrocketed 14227.56% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $98000.0 in 2021, then crashed by 46045.92% to -$45.0 million in 2022, then surged by 133.85% to $15.2 million in 2023, then tumbled by 93.67% to $964000.0 in 2024, then tumbled by 67.01% to $318000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Cash from Financing Activities are $318000.0 (Q4 2025), $365000.0 (Q3 2025), and $22.4 million (Q2 2025).